Novartis AG is 156.1x more valuable than Avidity Biosciences, Inc. by market capitalization ($283.13 B vs $1.81 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RNA | NVS |
|---|---|---|
| Market cap | $1.81 B | $283.13 B |
| US-listed rank | #2174 | #47 |
| Revenue (latest FY) | $18.75M | - |
| Net income (latest FY) | -$684.63M | - |
| Net margin | -3650.4% | - |
| SEC filings | 547 | 947 |
Novartis AG is 156.1x more valuable than Avidity Biosciences, Inc. by market capitalization ($283.13 B vs $1.81 B).
Full pages: Avidity Biosciences, Inc. and Novartis AG, or browse the full rankings.